FONR
FONAR Corporation NASDAQ$18.92
Mkt Cap $116.8M
52w Low $12.14
99.6% of range
52w High $18.95
50d MA $18.62
200d MA $16.66
P/E (TTM)
15.0x
EV/EBITDA
4.7x
P/B
0.8x
Debt/Equity
0.2x
ROE
4.8%
P/FCF
12.7x
RSI (14)
—
ATR (14)
—
Beta
0.99
50d MA
$18.62
200d MA
$16.66
Avg Volume
58.1K
About
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that all…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | AMC | — | 0.31 | — | 18.55 | +0.1% | -0.1% | -0.2% | +0.0% | +0.3% | +0.2% | — |
| Nov 10, 2025 | AMC | — | 0.34 | — | 14.97 | -1.6% | -1.1% | -0.8% | -1.6% | -1.7% | -3.9% | — |
| Sep 22, 2025 | AMC | — | 0.11 | — | 15.20 | +0.3% | +0.7% | +0.3% | +0.1% | +1.1% | -0.3% | — |
| May 15, 2025 | AMC | — | 0.37 | — | 13.54 | -1.6% | -4.7% | -0.2% | +4.4% | +1.2% | +3.1% | — |
| Feb 19, 2025 | AMC | — | 0.29 | — | 15.04 | +1.0% | -2.2% | -1.9% | -1.2% | -3.2% | -1.5% | — |
| Nov 12, 2024 | AMC | — | 0.46 | — | 15.44 | -0.3% | +1.8% | +0.3% | -2.7% | -3.7% | -4.4% | — |
| Sep 27, 2024 | AMC | — | 0.13 | — | 17.51 | -1.2% | -7.5% | -9.5% | -9.5% | -9.2% | -7.5% | — |
| May 15, 2024 | AMC | — | 0.27 | — | 16.27 | -0.6% | -3.4% | -6.3% | -11.6% | -11.4% | -4.9% | — |
| Feb 14, 2024 | AMC | — | 0.54 | — | 22.08 | +1.4% | +0.4% | +4.3% | +4.3% | +4.1% | +1.4% | — |
| Nov 14, 2023 | AMC | — | 0.59 | — | 16.31 | +0.1% | +6.1% | +3.2% | +2.7% | +11.8% | +12.6% | — |
Recent Filings
8-K
Fonar Corporation -- 8-K Filing
Fonar Corporation will mail proxy materials to shareholders regarding a proposed merger transaction, requiring stockholder approval at an upcoming meeting.
Feb 17
NT 10-Q
!! High
Fonar Corporation -- Late Quarterly Report -- Distress Signal
Fonar Corporation's delayed 10-Q filing for Q4 2025 suggests potential accounting or operational challenges that investors should monitor closely for disclosure of material issues.
Feb 9
Data updated apr 25, 2026 9:43am
· Source: massive.com